Myomo Announces It Has Entered Into The First Contracts That Will Allow MyoPro To Be Provided To Patients Covered By Private Insurance On An In-Network Basis

-2.78%

Myomo, Inc.

MYO

1.05

-2.78%

Blue Cross Blue Shield of Massachusetts and Paradigm together serve 3 million covered lives

Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces it has entered into the first contracts that will allow MyoPro to be provided to patients covered by private insurance on an in-network basis.

These new contracts are with Blue Cross Blue Shield of Massachusetts, a leading commercial and Medicare Advantage insurer, and Paradigm, a leading specialty care management organization serving workers' compensation and healthcare payers. Paradigm's contract represents its commitment to assessing and evaluating appropriateness of medical innovations like the MyoPro for injured workers. Together, these organizations cover approximately 3 million lives.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.